40 Yale, “Harvey Risch, MD, PhD Biography,” Yale School of Public Health (Jul. 15, 2019), https://ysph.yale.edu/profile/harvey_risch/
41 Peter A. McCullough, et al., The Pathophysiologic Basic and Clinical Rationale for Early Ambulatory Treatment of COVID19, V:134 I:1 The American Journal of Medicine P16-22, (Jan 1, 2021,) DOI: https://doi.org/10.1016/j.amjmed.2020.07.003. https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext
42 Peter A. McCullough, et al., Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID19), 30;21(4):517-530 Rev Cardiovasc Med. (Dec. 2020), doi: 10.31083/j.rcm.2020.04.264, https://pubmed.ncbi.nlm.nih.gov/33387997/
43 FLCCC, “Dr. Pierre Kory, M.P.A., M.D. curriculum vitae,” FLCCC Alliance, https://covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-Alliance-member-CV-Kory.pdf
44 Joel Rose, U.S. Field Hospitals Stand Down, Most Without Treating Any COVID19 Patients, NPR, (May 7, 2020). https://www.npr.org/2020/05/07/851712311/u-s-field-hospitals-stand-down-most-without-treating-any-covid19-patients
45 New York Times staff, Nearly One-Third of U.S. Coronavirus Deaths Are Linked to Nursing Homes, (Jun 1, 2021). New York Times, https://www.nytimes.com/interactive/2020/us/coronavirus-nursing-homes.html
46 New York Times staff, Nearly One-Third of U.S. Coronavirus Deaths Are Linked to Nursing Homes, (Jun 1, 2021). New York Times, https://www.nytimes.com/interactive/2020/us/coronavirus-nursing-homes.html
47 The FLCCC Alliance, FLCCC (2021), https://covid19criticalcare.com/network-support/the-flccc-alliance/
48 Paul G. Harch, Hyperbaric oxygen treatment of novel coronavirus (COVID19) respiratory failure, Medical Gas Research, ()pr-Jun, 2020). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7885706/
49 Scott A Gorenstein et al, Hyperbaric oxygen therapy for COVID19 patients with respiratory distress: treated cases versus propensity-matched controls, Undersea & Hyperbaric Medical Society, (Third-quarter, 2020). https://pubmed.ncbi.nlm.nih.gov/32931666/
50 Saikiran Kannan, Did nasal rinsing help ASEAN control pandemic or swift action?, India Today, (jul 24, 2020). https://www.indiatoday.in/news-analysis/story/did-nasal-rinsing-help-asean-control-pandemic-or-swift-action-1703801-2020-07-24
51 Peter A. McCullough et al., The Pathophysiologic Basic and Clinical Rationale for Early Ambulatory Treatment of COVID19, V:134 I:1 The American Journal of Medicine P16-22, (Jan 1, 2021,) DOI: https://doi.org/10.1016/j.amjmed.2020.07.003. https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext
52 Jianjun Gao et al, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID19 associated pneumonia in clinical studies, BioScience Trends, (Mar 26, 2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID19 associated pneumonia in clinical studies 53 National Health Commission & State Administration of Traditional Chinese Medicine, Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia, (Mar 3, 2020). https://www.chinalawtranslate.com/wp-content/uploads/2020/03/Who-translation.pdf
54 Aimee Quin, Interview with Robert F. Kennedy, Jr., (Oct. 1, 2021).
55 AAPS, “Physician List & Guide to Home-Based COVID Treatment,” AAPS (Aug. 28, 2021), https://aapsonline.org/covidpatientguide/
56 The WHO Rapid Evidence Appraisal for COVID19 Therapies (REACT) Working Group, Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID19 A Meta-analysis, (Sep 22, 2020). https://jamanetwork.com/journals/jama/fullarticle/2770279
57 Univesity of Oxford, Common asthma treatment reduces need for hospitalisation in COVID19 patients, study suggests, (Feb 9, 2021). Common asthma treatment reduces need for hospitalisation in COVID19 patients, study suggests 58 Ly-Mee Yu, DPhil et al, Inhaled budesonide for COVID19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial, The Lancet, (Aug 10, 2021). https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01744-X/fulltext
59 Aaron Z. Reyes et al, Anti-inflammatory therapy for COVID19 infection: the case for colchicine, Annals of the Rheumatic Diseases, (May, 2021). https://pubmed.ncbi.nlm.nih.gov/33293273/
60 Peter A. McCullough et al, Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID19), Reviews in Cardiovascular Medicine, (2020). https://rcm.imrpress.com/article/2020/2153-8174/RCM2020264.shtml
61 R. Derwanda, M. Scholzb, & V. Zelenko, “COVID19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study,” International Journal of Antimicrobial Agents, Volume 56, Issue 6, Dec 2020, 106214, https://doi.org/10.1016/j.ijantimicag.2020.106214, https://www.sciencedirect.com/science/article/pii/S0924857920304258
62 McMaster University, Antidepressant fluvoxamine can save COVID19 patients, McMaster-led research shows, (Aug 17, 2021). https://brighterworld.mcmaster.ca/articles/antidepressant-fluvoxamine-can-save-covid19-patients-mcmaster-led-research-shows/
63 Gilmar Reis, et al., “Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID19: The TOGETHER Randomized Clinical Trial,” JAMA Netw. Open, 4(4):e216468 (Apr. 22, 2021), doi:10.1001/ jamanetworkopen.2021.6468. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779044
64 Paul E. Alexander, et al., Early multidrug treatment of SARS-CoV-2 infection (COVID19) and reduced mortality among nursing home (or outpatient/ambulatory) residents, V: 153 ISSN: 0306-9877 (Aug. 2021), https://doi.org/10.1016/j.mehy.2021.110622.
65 Juan IgnacioMorán Blanco, et al., Antihistamines and azithromycin as a treatment for COVID19 on primary health care – A retrospective observational study in elderly patients, V: 67 ISSN 1094-5539 (Apr. 2021), https://doi.org/10.1016/j.pupt.2021.101989.
66 Peter A. McCullough, et al., Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID19), 30;21(4):517-530 Rev Cardiovasc Med. (Dec. 2020), doi: 10.31083/j.rcm.2020.04.264, https://pubmed.ncbi.nlm.nih.gov/33387997/
67 The New York Times, “See How the Vaccine Rollout Is Going in Your State,” NYT (Jan. 31, 2021), https://web.archive.org/web/20210201124039/https://www.nytimes.com/interactive/2020/us/covid19-vaccine-doses.html
Endnotes - Killing Hydroxychloroquine
1 Bill & Melinda Gates Foundation, 2018 Form 990, Attachment C, page 4, (2018). https://www.causeiq.com/organizations/view_990/911663695/011be856013f829aa3c948c35c2aa163